In silico experiments of existing and hypothetical cytokine-directed clinical trials using agent-based modeling*
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Critical Care and Intensive Care Medicine
Reference44 articles.
1. Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study
2. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis
3. Recombinant Humanized Monoclonal Antibody against CD18 (rhu MAb CD18) in Traumatic Hemorrhagic Shock: Results of a Phase II Clinical Trial
4. Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome
Cited by 187 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessing the Role of Patient Generation Techniques in Virtual Clinical Trial Outcomes;Bulletin of Mathematical Biology;2024-08-13
2. Assessing the Role of Patient Generation Techniques in Virtual Clinical Trial Outcomes;2024-06-12
3. Creating a Roadmap to Quantitative Systems Pharmacology–Informed Rare Disease Drug Development: A Workshop Report;Clinical Pharmacology & Therapeutics;2023-11-20
4. Characterizing the Crosstalk Between Programmed Cell Death Pathways in Cytokine Storm With an Agent-Based Model;Surgical Infections;2023-10-01
5. What’s next for computational systems biology?;Frontiers in Systems Biology;2023-09-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3